Healthcare Sector Review: Winning and Losing Stocks

Wall St. Watchdog reveals information about today’s action in the Healthcare (NYSE:XLV) sector:

Gainers (% price change)

  • Skilled Healthcare Group (NYSE:SKH): The shares closed at $3.76, up $0.23, or 6.52%, on the day. Its market capitalization is $142.95 million. About the company: Skilled Healthcare Group Inc. operates nursing and assisted-living homes in California, Texas, Kansas, and Nevada.
  • SIGA Technologies, Inc. (NASDAQ:SIGA): The shares closed at $2.93, up $0.14, or 5.02%, on the day. Its market capitalization is $150.35 million. About the company: SIGA Technologies, Inc. explores, develops, and markets products for use in defense against biological warfare agents. The Company’s also offers products such as novel anti-infectives or the prevention and treatment of serious infectious diseases.
  • BioScrip Inc. (NASDAQ:BIOS): The shares closed at $6.09, up $0.28, or 4.82%, on the day. Its market capitalization is $333.17 million. About the company: BioScrip, Inc. is a pharmacy benefit management and specialty pharmaceutical organization that partners with managed care organizations and healthcare providers to control prescription drug costs. The Company provides pharmacy benefit products and services and mail order pharmacy services, and is the fulfillment center for online retailers offering prescription and OTC products.
  • BioMarin Pharmaceutical (NASDAQ:BMRN): The shares closed at $31.80, up $0.97, or 3.15%, on the day. Its market capitalization is $3.56 billion. About the company: BioMarin Pharmaceutical Inc. develops and commercializes therapeutic enzyme products. The Company has applied its proprietary enzyme technology to develop products for lysosomal storage diseases and for the treatment of serious burns. BioMarin’s subsidiary provides analytical and diagnostic products and services in the area of carbohydrate biology.
  • Neogen Corporation (NASDAQ:NEOG): The shares closed at $33.90, up $1.02, or 3.1%, on the day. Its market capitalization is $790.40 million. About the company: Neogen Corporation develops and markets products and services dedicated to food and animal safety. The Company’s diagnostic products are used by food and animal producers to test for foodborne bacteria, food allergen, natural toxins, drug and chemical residues, plant diseases, and quality assurance.

Losers (% price change)

  • Inhibitex, Inc. (NASDAQ:INHX): The shares closed at $2.58, down $0.32, or 11.03%, on the day. Its market capitalization is $201.72 million. About the company: Inhibitex Inc. is a biopharmaceutical company that discovers, develops, and commercializes novel antibody-based products. The Company develops products for the prevention and treatment of serious bacterial and fungal infections in the hospital setting.
  • Senomyx Inc. (NASDAQ:SNMX): The shares closed at $3.50, down $0.41, or 10.49%, on the day. Its market capitalization is $138.73 million. About the company: Senomyx, Inc. discovers new proprietary flavor and fragrance molecules for use in a wide range of consumer products. The company’s flavor and fragrance molecules are used by consumer products companies to improve the taste or smell of many products, including processed foods, beverages, perfumes and personal and home care products.
  • Vical Incorporated (NASDAQ:VICL): The shares closed at $2.43, down $0.27, or 10%, on the day. Its market capitalization is $174.57 million. About the company: Vical Incorporated develops gene-based pharmaceutical products for human therapy. The Company develops cancer product candidates, as well as develops vaccines for infectious diseases and gene-based delivery of therapeutic proteins for other disorders.
  • SciClone Pharmaceuticals (NASDAQ:SCLN): The shares closed at $3.71, down $0.41, or 9.95%, on the day. Its market capitalization is $216.37 million. About the company: SciClone Pharmaceuticals, Inc. is a global biopharmaceutical company that acquires, develops, and commercializes specialist-oriented drugs. The Company’s products are for treating chronic and life-threatening diseases such as cancer, hepatitis B, hepatitis C, cystic fibrosis, and immune system disorders.
  • Idenix Pharmaceuticals (NASDAQ:IDIX): The shares closed at $4.86, down $0.53, or 9.83%, on the day. Its market capitalization is $467.31 million. About the company: Idenix Pharmaceuticals Inc. is a biopharmaceutical company that discovers and develops drugs for the treatment of human viral and other infectious diseases. The Company is focusing on the treatment of infections caused by hepatitis B virus, hepatitis C virus, and human immunodeficiency virus (HIV).

(Note: Selected financial data are sourced from Google Finance. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>